JCbio was founded in 2005 under the goal of supplying innovative bio products to Korean bio researchers. Early in 2010, JCbio laid the foundation of growth by exclusively supplying to Korean researchers those products through the strategic partnership with CISBIO(France), Next Advance(USA) and BEX(Japan). In 2011, JCbio was certified as a Bio Venture company by the Ministry of SMEs and Startups, and has grown into Bio R&D company in earnest by establishing JCbio Research Institute at ABMRC in Yonsei University Medical Center. In 2013, JCBio R&D project was selected by Ministry of SMEs and Startups, and had been evaluated as an excellent research company and had laid a foothold to take a leap forward. The ongoing R&D project, “Development and production of Ocular Implant” was certified by GMP and ISO 13485, and We are conducting clinical trial (2020-2023) in Korea and plan to sell domestic and global markets from 2023. In 2018, JCBio was selected as Strategy sales and marketing partner of Oxford Nanopore Technologies regarded as the most innovative NGS company in the world, and supplying Nanopore sequencing products and technologies to Korean researchers.